{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T04:12:32Z","timestamp":1791346352781,"version":"4.3.1"},"reference-count":42,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2023,6,1]],"date-time":"2023-06-01T00:00:00Z","timestamp":1685577600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,6,1]],"date-time":"2023-06-01T00:00:00Z","timestamp":1685577600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,5,27]],"date-time":"2023-05-27T00:00:00Z","timestamp":1685145600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["elsevier.es","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Anales de Pediatr\u00eda (English Edition)"],"published-print":{"date-parts":[[2023,6]]},"DOI":"10.1016\/j.anpede.2023.03.010","type":"journal-article","created":{"date-parts":[[2023,5,31]],"date-time":"2023-05-31T08:04:30Z","timestamp":1685520270000},"page":"446-459","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"title":["Consensus document on the management of febrile neutropenia in paediatric haematology and oncology patients of the Spanish Society of Pediatric Infectious Diseases (SEIP) and the Spanish Society of Pediatric Hematology and Oncology (SEHOP)"],"prefix":"10.1016","volume":"98","author":[{"given":"Leticia","family":"Mart\u00ednez Campos","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paula","family":"P\u00e9rez-Albert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laia","family":"Ferres Ramis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elena Mar\u00eda","family":"Rinc\u00f3n-L\u00f3pez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Natalia","family":"Mendoza-Palomar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pere","family":"Soler-Palacin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Aguilera-Alonso","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.anpede.2023.03.010_bib0005","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1111\/bjh.13113","article-title":"Mucosal barrier injury, fever and infection in neutropenic patients with cancer: introducing the paradigm febrile mucositis","volume":"167","author":"van der Velden","year":"2014","journal-title":"Br J Haematol"},{"key":"10.1016\/j.anpede.2023.03.010_bib0010","doi-asserted-by":"crossref","first-page":"940044","DOI":"10.3389\/froh.2022.940044","article-title":"The potential contribution of dental foci and oral mucositis to febrile neutropenia in patients treated with myelosuppressive chemotherapy for solid tumors and lymphoma","volume":"3","author":"Zecha","year":"2022","journal-title":"Front Oral Health"},{"key":"10.1016\/j.anpede.2023.03.010_bib0015","doi-asserted-by":"crossref","first-page":"1774","DOI":"10.1200\/JCO.22.02224","article-title":"Guideline for the management of fever and neutropenia in children with cancer and hematopoietic stem-cell transplantation recipients: 2023 update","volume":"41","author":"Lehrnbecher","year":"2023","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.anpede.2023.03.010_bib0020","doi-asserted-by":"crossref","first-page":"e270","DOI":"10.1016\/S1470-2045(20)30725-7","article-title":"8th European Conference on Infections in Leukaemia: 2020 guidelines for the use of antibiotics in paediatric patients with cancer or post-haematopoietic cell transplantation","volume":"22","author":"Lehrnbecher","year":"2021","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.anpede.2023.03.010_bib0025","doi-asserted-by":"crossref","first-page":"857","DOI":"10.4067\/s0716-10182021000600857","article-title":"Manejo de los episodios de neutropenia febril en ni\u00f1os con c\u00e1ncer. Consenso de la Sociedad Latinoamericana de Infectolog\u00eda Pedi\u00e1trica 2021","volume":"38","author":"Santolaya","year":"2021","journal-title":"Rev Chil Infectol"},{"key":"10.1016\/j.anpede.2023.03.010_bib0030","doi-asserted-by":"crossref","first-page":"880","DOI":"10.3390\/jcm11030880","article-title":"Characteristics and outcomes of bloodstream infections in a Tertiary-Care Pediatric Hematology-Oncology Unit: a 10-year study","volume":"11","author":"Mattei","year":"2022","journal-title":"J Clin Med"},{"key":"10.1016\/j.anpede.2023.03.010_bib0035","doi-asserted-by":"crossref","first-page":"1086","DOI":"10.3390\/children8121086","article-title":"Update on febrile neutropenia in pediatric oncological patients undergoing chemotherapy","volume":"8","author":"Cennamo","year":"2021","journal-title":"Children"},{"key":"10.1016\/j.anpede.2023.03.010_bib0040","doi-asserted-by":"crossref","first-page":"266","DOI":"10.3390\/antibiotics10030266","article-title":"Antibiotic resistant bloodstream infections in pediatric patients receiving chemotherapy or hematopoietic stem cell transplant: factors associated with development of resistance, intensive care admission and mortality","volume":"10","author":"Castagnola","year":"2021","journal-title":"Antibiotics (Basel)"},{"key":"10.1016\/j.anpede.2023.03.010_bib0045","doi-asserted-by":"crossref","first-page":"e298","DOI":"10.1017\/S0950268819001845","article-title":"Comparison of epidemiological, clinical and microbiological characteristics of bloodstream infection in children with solid tumours and haematological malignancies","volume":"147","author":"Garrido","year":"2019","journal-title":"Epidemiol Infect"},{"key":"10.1016\/j.anpede.2023.03.010_bib0050","doi-asserted-by":"crossref","first-page":"e6692827","DOI":"10.1155\/2021\/6692827","article-title":"The pattern of microorganisms and drug susceptibility in pediatric oncologic patients with febrile neutropenia","volume":"2021","author":"Jungrungrueng","year":"2021","journal-title":"J Pathog"},{"key":"10.1016\/j.anpede.2023.03.010_bib0055","doi-asserted-by":"crossref","first-page":"e160","DOI":"10.1097\/MPH.0000000000002258","article-title":"Bloodstream infections in children with cancer: pathogen distribution and antimicrobial susceptibility patterns over a 10-year period","volume":"44","author":"Maarbjerg","year":"2022","journal-title":"J Pediatr Hematol Oncol"},{"key":"10.1016\/j.anpede.2023.03.010_bib0060","doi-asserted-by":"crossref","first-page":"e445","DOI":"10.1097\/MPH.0000000000001814","article-title":"Pediatric febrile neutropenia: change in etiology of bacteremia, empiric choice of therapy and clinical outcomes","volume":"42","author":"Alali","year":"2020","journal-title":"J Pediatr Hematol Oncol"},{"key":"10.1016\/j.anpede.2023.03.010_bib0065","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1097\/INF.0000000000002611","article-title":"Detection of respiratory viruses in the clinical outcome of children with fever and neutropenia","volume":"39","author":"Cerdeira Barreiro","year":"2020","journal-title":"Pediatr Infect Dis J"},{"key":"10.1016\/j.anpede.2023.03.010_bib0070","doi-asserted-by":"crossref","first-page":"e28570","DOI":"10.1002\/pbc.28570","article-title":"Impact of respiratory viral panel testing on length of stay in pediatric cancer patients admitted with fever and neutropenia","volume":"67","author":"Shinn","year":"2020","journal-title":"Pediatr Blood Cancer"},{"key":"10.1016\/j.anpede.2023.03.010_bib0075","doi-asserted-by":"crossref","first-page":"100394","DOI":"10.1016\/j.eclinm.2020.100394","article-title":"Re-evaluating and recalibrating predictors of bacterial infection in children with cancer and febrile neutropenia","volume":"23","author":"Haeusler","year":"2020","journal-title":"EClinicalMedicine"},{"key":"10.1016\/j.anpede.2023.03.010_bib0080","doi-asserted-by":"crossref","first-page":"2843","DOI":"10.1016\/j.ejca.2009.06.003","article-title":"Successful introduction and audit of a step-down oral antibiotic strategy for low risk paediatric febrile neutropaenia in a UK, multicentre, shared care setting","volume":"45","author":"Dommett","year":"2009","journal-title":"Eur J Cancer"},{"key":"10.1016\/j.anpede.2023.03.010_bib0085","doi-asserted-by":"crossref","DOI":"10.1136\/archdischild-2014-306237.236","article-title":"G239 validation of two risk stratification guidelines in a one year cohort of febrile admissions in paediatric oncology patients in a UK centre","volume":"99","author":"Arif","year":"2014","journal-title":"Arch Dis Child"},{"key":"10.1016\/j.anpede.2023.03.010_bib0090","doi-asserted-by":"crossref","first-page":"2167","DOI":"10.1002\/pbc.26121","article-title":"Risk-stratification management of febrile neutropenia in pediatric hematology-oncology patients: results of a French nationwide survey","volume":"63","author":"Delebarre","year":"2016","journal-title":"Pediatr Blood Cancer"},{"key":"10.1016\/j.anpede.2023.03.010_bib0095","doi-asserted-by":"crossref","first-page":"e02183","DOI":"10.1128\/AAC.02183-19","article-title":"Carbapenem-resistant Gram-negative bacterial infections in children","volume":"64","author":"Aguilera-Alonso","year":"2020","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.anpede.2023.03.010_bib0100","doi-asserted-by":"crossref","first-page":"152","DOI":"10.3109\/23744235.2015.1087647","article-title":"Incidence of colonization and bloodstream infection with carbapenem-resistant Enterobacteriaceae in children receiving antineoplastic chemotherapy in Italy","volume":"48","author":"Caselli","year":"2016","journal-title":"Infect Dis"},{"key":"10.1016\/j.anpede.2023.03.010_bib0105","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1097\/INF.0000000000003322","article-title":"Validation of the Giannella Risk Score for the prediction of infection by carbapenemase-producing Enterobacteriaceae in the pediatric population","volume":"41","author":"Garazzino","year":"2022","journal-title":"Pediatr Infect Dis J"},{"key":"10.1016\/j.anpede.2023.03.010_bib0110","doi-asserted-by":"crossref","first-page":"e01744","DOI":"10.1128\/AAC.01744-21","article-title":"Impact of empirical antibiotic regimens on mortality in neutropenic patients with bloodstream infection presenting with septic shock","volume":"66","author":"Chumbita","year":"2022","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.anpede.2023.03.010_bib0115","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1093\/jpids\/piz002","article-title":"Defining the role of novel \u03b2-lactam agents that target carbapenem-resistant Gram-negative organisms","volume":"8","author":"Tamma","year":"2019","journal-title":"J Pediatr Infect Dis Soc"},{"key":"10.1016\/j.anpede.2023.03.010_bib0120","doi-asserted-by":"crossref","first-page":"351.e1","DOI":"10.1016\/j.anpedi.2019.08.002","article-title":"Documento de posicionamiento de la Asociaci\u00f3n Espa\u00f1ola de Pediatr\u00eda-Sociedad Espa\u00f1ola de Infectolog\u00eda Pedi\u00e1trica (AEP-SEIP) sobre el tratamiento de las infecciones por bacterias multirresistentes","volume":"91","author":"Aguilera-Alonso","year":"2019","journal-title":"An Pediatr\u00eda"},{"key":"10.1016\/j.anpede.2023.03.010_bib0125","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1016\/j.cmi.2018.07.026","article-title":"Current time-to-positivity of blood cultures in febrile neutropenia: a tool to be used in stewardship de-escalation strategies","volume":"25","author":"Puerta-Alcalde","year":"2019","journal-title":"Clin Microbiol Infect"},{"key":"10.1016\/j.anpede.2023.03.010_bib0130","doi-asserted-by":"crossref","first-page":"1056","DOI":"10.1016\/j.jmii.2020.07.014","article-title":"Analysis of antibiotics discontinuation during bone marrow suppression in childhood, adolescent and young adult patients with febrile neutropenia","volume":"54","author":"Kobayashi","year":"2021","journal-title":"J Microbiol Immunol Infect"},{"key":"10.1016\/j.anpede.2023.03.010_bib0135","doi-asserted-by":"crossref","first-page":"1283","DOI":"10.2147\/IDR.S238567","article-title":"Optimising antimicrobial selection and duration in the treatment of febrile neutropenia in children","volume":"14","author":"Morgan","year":"2021","journal-title":"Infect Drug Resist"},{"key":"10.1016\/j.anpede.2023.03.010_bib0140","first-page":"3819","article-title":"Predictive value of PCT and IL-6 for bacterial infection in children with cancer and febrile neutropenia","volume":"26","author":"Van der Gali\u00ebn","year":"2018","journal-title":"Support Care Cancer"},{"key":"10.1016\/j.anpede.2023.03.010_bib0145","doi-asserted-by":"crossref","first-page":"e334","DOI":"10.1097\/MPH.0000000000002242","article-title":"Pediatric invasive fungal risk score in cancer and hematopoietic stem cell transplantation patients with febrile neutropenia","volume":"44","author":"Alali","year":"2022","journal-title":"J Pediatr Hematol Oncol"},{"key":"10.1016\/j.anpede.2023.03.010_bib0150","first-page":"94","article-title":"Invasive fungal infections in children with leukemia: clinical features and prognosis","volume":"39","author":"Sezgin Evim","year":"2022","journal-title":"Turk J Hematol"},{"key":"10.1016\/j.anpede.2023.03.010_bib0155","doi-asserted-by":"crossref","first-page":"e254","DOI":"10.1016\/S1470-2045(20)30723-3","article-title":"8th European Conference on Infections in Leukaemia: 2020 guidelines for the diagnosis, prevention, and treatment of invasive fungal diseases in paediatric patients with cancer or post-haematopoietic cell transplantation","volume":"22","author":"Groll","year":"2021","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.anpede.2023.03.010_bib0160","doi-asserted-by":"crossref","first-page":"674","DOI":"10.1086\/590566","article-title":"Defining responses to therapy and study outcomes in clinical trials of invasive fungal diseases: Mycoses Study Group and European Organization for Research and Treatment of Cancer consensus criteria","volume":"47","author":"Segal","year":"2008","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.anpede.2023.03.010_bib0165","doi-asserted-by":"crossref","first-page":"S32","DOI":"10.1093\/jpids\/pix054","article-title":"Role of molecular biomarkers in the diagnosis of invasive fungal diseases in children","volume":"6","author":"Huppler","year":"2017","journal-title":"J Pediatr Infect Dis Soc"},{"key":"10.1016\/j.anpede.2023.03.010_bib0170","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1080\/14787210.2019.1626718","article-title":"The clinical management of invasive mold infection in children with cancer or undergoing hematopoietic stem cell transplantation","volume":"17","author":"Lehrnbecher","year":"2019","journal-title":"Expert Rev Anti Infect Ther"},{"key":"10.1016\/j.anpede.2023.03.010_bib0175","doi-asserted-by":"crossref","first-page":"S22","DOI":"10.1093\/jpids\/pix055","article-title":"Diagnostic imaging and invasive fungal diseases in children","volume":"6","author":"Katragkou","year":"2017","journal-title":"J Pediatr Infect Dis Soc"},{"key":"10.1016\/j.anpede.2023.03.010_bib0180","doi-asserted-by":"crossref","first-page":"1367","DOI":"10.1093\/cid\/ciz1008","article-title":"Revision and update of the consensus definitions of invasive fungal disease from the European Organization for Research and Treatment of Cancer and the Mycoses Study Group Education and Research Consortium","volume":"71","author":"Donnelly","year":"2020","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.anpede.2023.03.010_bib0185","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1097\/INF.0000000000002530","article-title":"Etiology and outcome of candidemia in neonates and children in Europe: an 11-year multinational retrospective study","volume":"39","author":"Warris","year":"2020","journal-title":"Pediatr Infect Dis J"},{"key":"10.1016\/j.anpede.2023.03.010_bib0190","doi-asserted-by":"crossref","first-page":"2860","DOI":"10.1093\/jac\/dky244","article-title":"Efficacy of pre-emptive versus empirical antifungal therapy in children with cancer and high-risk febrile neutropenia: a randomized clinical trial","volume":"73","author":"Santolaya","year":"2018","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.anpede.2023.03.010_bib0195","doi-asserted-by":"crossref","first-page":"e1","DOI":"10.1093\/cid\/civ933","article-title":"Clinical practice guideline for the management of candidiasis: 2016 update by the Infectious Diseases Society of America","volume":"62","author":"Pappas","year":"2016","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.anpede.2023.03.010_bib0200","doi-asserted-by":"crossref","first-page":"70517","DOI":"10.3389\/fped.2021.705179","volume":"9","author":"Ifversen","year":"2021","journal-title":"Front Pediatr"},{"key":"10.1016\/j.anpede.2023.03.010_bib0205","doi-asserted-by":"crossref","first-page":"100220","DOI":"10.1016\/j.eclinm.2019.11.013","article-title":"Australian PICNICC study group and the PREDICT network. Risk stratification in children with cancer and febrile neutropenia: a national, prospective, multicentre validation of nine clinical decision rules","volume":"18","author":"Haeusler","year":"2020","journal-title":"EClinicalMedicine"},{"key":"10.1016\/j.anpede.2023.03.010_bib0210","unstructured":"SEIP. Dosis de antibi\u00f3ticos. Available from: https:\/\/www.seipweb.es\/dosis-de-antibioticos\/."}],"container-title":["Anales de Pediatr\u00eda (English Edition)"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2341287923001114?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2341287923001114?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,6]],"date-time":"2025-11-06T09:46:02Z","timestamp":1762422362000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2341287923001114"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,6]]},"references-count":42,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2023,6]]}},"alternative-id":["S2341287923001114"],"URL":"https:\/\/doi.org\/10.1016\/j.anpede.2023.03.010","relation":{},"ISSN":["2341-2879"],"issn-type":[{"value":"2341-2879","type":"print"}],"subject":[],"published":{"date-parts":[[2023,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Consensus document on the management of febrile neutropenia in paediatric haematology and oncology patients of the Spanish Society of Pediatric Infectious Diseases (SEIP) and the Spanish Society of Pediatric Hematology and Oncology (SEHOP)","name":"articletitle","label":"Article Title"},{"value":"Anales de Pediatr\u00eda (English Edition)","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.anpede.2023.03.010","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"https:\/\/doi.org\/10.1016\/j.anpedi.2023.03.012","name":"associatedlink","label":"CrossRef DOI link to the associated document"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Asociaci\u00f3n Espa\u00f1ola de Pediatr\u00eda. Published by Elsevier Espa\u00f1a, S.L.U.","name":"copyright","label":"Copyright"}]}}